Your browser version may not work well with NCBI's Web applications. More information here...

Recent Activity

Items 1 - 20 of 78
of 4Next
1:

The effects of a low-carbohydrate, ketogenic diet on the polycystic ovary syndrome: a pilot study.

Mavropoulos JC, Yancy WS, Hepburn J, Westman EC.

Nutr Metab (Lond). 2005 Dec 16;2:35.

PMID: 16359551 [PubMed]

3:

A randomized trial of the effects of two types of short-term hypocaloric diets on weight loss in women with polycystic ovary syndrome.

Stamets K, Taylor DS, Kunselman A, Demers LM, Pelkman CL, Legro RS.

Fertil Steril. 2004 Mar;81(3):630-7.

PMID: 15037413 [PubMed - indexed for MEDLINE]

4:

Glucose intolerance in Japanese patients with polycystic ovary syndrome.

Kurioka H, Takahashi K, Miyazaki K.

Arch Gynecol Obstet. 2007 Mar;275(3):169-73. Epub 2006 Sep 14.

PMID: 16972071 [PubMed - indexed for MEDLINE]

5:

Plasma metastin levels are negatively correlated with insulin resistance and free androgens in women with polycystic ovary syndrome.

Panidis D, Rousso D, Koliakos G, Kourtis A, Katsikis I, Farmakiotis D, Votsi E, Diamanti-Kandarakis E.

Fertil Steril. 2006 Jun;85(6):1778-83. Epub 2006 May 2.

PMID: 16650418 [PubMed - indexed for MEDLINE]

6:

Effect of long-term orlistat treatment on serum levels of advanced glycation end-products in women with polycystic ovary syndrome.

Diamanti-Kandarakis E, Katsikis I, Piperi C, Alexandraki K, Panidis D.

Clin Endocrinol (Oxf). 2007 Jan;66(1):103-9.

PMID: 17201808 [PubMed - indexed for MEDLINE]

7:

C-reactive protein before and after weight loss in overweight women with and without polycystic ovary syndrome.

Moran LJ, Noakes M, Clifton PM, Wittert GA, Belobrajdic DP, Norman RJ.

J Clin Endocrinol Metab. 2007 Aug;92(8):2944-51. Epub 2007 May 15.

PMID: 17504892 [PubMed - indexed for MEDLINE]

8:

Difference in dietary intake between women with polycystic ovary syndrome and healthy controls.

Douglas CC, Norris LE, Oster RA, Darnell BE, Azziz R, Gower BA.

Fertil Steril. 2006 Aug;86(2):411-7. Epub 2006 Jun 8.

PMID: 16762348 [PubMed - indexed for MEDLINE]

9:

The use of anti-mullerian hormone in predicting menstrual response after weight loss in overweight women with polycystic ovary syndrome.

Moran LJ, Noakes M, Clifton PM, Norman RJ.

J Clin Endocrinol Metab. 2007 Oct;92(10):3796-802. Epub 2007 Jul 24.

PMID: 17652213 [PubMed - indexed for MEDLINE]

10:

The effects of rosiglitazone and metformin on insulin resistance and serum androgen levels in obese and lean patients with polycystic ovary syndrome.

Yilmaz M, Biri A, Karakoç A, Törüner F, Bingöl B, Cakir N, Tiras B, Ayvaz G, Arslan M.

J Endocrinol Invest. 2005 Dec;28(11):1003-8.

PMID: 16483179 [PubMed - indexed for MEDLINE]

11:

A low-carbohydrate, ketogenic diet to treat type 2 diabetes.

Yancy WS Jr, Foy M, Chalecki AM, Vernon MC, Westman EC.

Nutr Metab (Lond). 2005 Dec 1;2:34.

PMID: 16318637 [PubMed]

13:

Lower insulin sensitivity differentiates hirsute from non-hirsute Sicilian women with polycystic ovary syndrome.

Amato MC, Galluzzo A, Merlino S, Mattina A, Richiusa P, Criscimanna A, Giordano C.

Eur J Endocrinol. 2006 Dec;155(6):859-65.

PMID: 17132756 [PubMed - indexed for MEDLINE]

14:

Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome.

Hahn S, Haselhorst U, Tan S, Quadbeck B, Schmidt M, Roesler S, Kimmig R, Mann K, Janssen OE.

Exp Clin Endocrinol Diabetes. 2006 Nov;114(10):577-83.

PMID: 17177140 [PubMed - indexed for MEDLINE]

15:

Role of diet in the treatment of polycystic ovary syndrome.

Douglas CC, Gower BA, Darnell BE, Ovalle F, Oster RA, Azziz R.

Fertil Steril. 2006 Mar;85(3):679-88.

PMID: 16500338 [PubMed - indexed for MEDLINE]

16:

Effects of metformin treatment in women with polycystic ovary syndrome depends on insulin resistance.

Nawrocka J, Starczewski A.

Gynecol Endocrinol. 2007 Apr;23(4):231-7.

PMID: 17505944 [PubMed - indexed for MEDLINE]

17:

Short-term meal replacements followed by dietary macronutrient restriction enhance weight loss in polycystic ovary syndrome.

Moran LJ, Noakes M, Clifton PM, Wittert GA, Williams G, Norman RJ.

Am J Clin Nutr. 2006 Jul;84(1):77-87.

PMID: 16825684 [PubMed - indexed for MEDLINE]

18:

Insulin-like factor 3: a new circulating hormone related to luteinizing hormone-dependent ovarian hyperandrogenism in the polycystic ovary syndrome.

Gambineri A, Patton L, De Iasio R, Palladoro F, Pagotto U, Pasquali R.

J Clin Endocrinol Metab. 2007 Jun;92(6):2066-73. Epub 2007 Mar 13.

PMID: 17356050 [PubMed - indexed for MEDLINE]

19:

Flow-mediated dilatation in overweight and obese women with polycystic ovary syndrome.

Brinkworth GD, Noakes M, Moran LJ, Norman R, Clifton PM.

BJOG. 2006 Nov;113(11):1308-14.

PMID: 17059392 [PubMed - indexed for MEDLINE]

20:

Increased activation of nuclear factor kappaB triggers inflammation and insulin resistance in polycystic ovary syndrome.

González F, Rote NS, Minium J, Kirwan JP.

J Clin Endocrinol Metab. 2006 Apr;91(4):1508-12. Epub 2006 Feb 7.

PMID: 16464947 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 78
of 4Next